Stock 460 SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sihuan Pharmaceutical Holdings Group Ltd.

Equities

460

BMG8162K1137

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:42 28/06/2024 pm IST 		5-day change 1st Jan Change
0.52 HKD -3.70% Intraday chart for Sihuan Pharmaceutical Holdings Group Ltd. -5.45% -20.00%
27/06 Sihuan Pharma Unit's Microvascular Disease Drug Gets China Registration Approval MT
26/06 Chinese Regulator Approves Drug Registration for Sihuan Pharmaceutical's Subsidiary's Ticagrelor Orodispersible MT

Business Summary

Sihuan Pharmaceutical Holdings Group Ltd is a holding company mainly engaged in pharmaceutical manufacturing business. The Company operates three segments. Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. Innovative Medicine and Other Medicine segment is engaged in the research and development of innovative drugs in the fields of digestion, oncology, non-alcoholic hepatitis, diabetes and complications. The Company also operates Generic Medicine segment.

Number of employees: 2,872

Sales per Business

HKD in Million2022Weight2023Weight Delta
Generic Medicine
75.2 %
2,291 90.3 % 1,546 75.2 % -32.54%
Medical Aesthetic Products
24.2 %
174 6.9 % 497 24.2 % +185.41%
Innovative Medicine and Other Medicine
0.6 %
71 2.8 % 13 0.6 % -81.58%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
99.3 %
2,520 99.3 % 2,041 99.3 % -19.01%
United States
0.7 %
17 0.7 % 15 0.7 % -9.05%

Managers

Managers TitleAgeSince
Wei Cheng Guo FOU
 Founder 60 01/01/01
Gui Li Miao DFI
 Director of Finance/CFO 50 -
Zhong Xin Jia COO
 Chief Operating Officer 65 01/07/01
Jiong Long Zhang CIO
 Chief Investment Officer 62 18/06/18
Yan Ling Chen BRD
 Director/Board Member 46 01/06/01
Kin Wai Li SEC
 Corporate Secretary 35 17/22/17
Bo Xu SAM
 Sales & Marketing 49 01/16/01

Members of the board

Members of the board TitleAgeSince
Feng Sheng Che FOU
 Founder 63 01/01/01
Wei Cheng Guo FOU
 Founder 60 01/01/01
Jiong Long Zhang CIO
 Chief Investment Officer 62 18/06/18
Xun Zhu BRD
 Director/Board Member 66 20/14/20
Wah Kwong Tsang BRD
 Director/Board Member 71 04/13/04
Yan Ling Chen BRD
 Director/Board Member 46 01/06/01
Guan Wang BRD
 Director/Board Member 43 01/23/01
Gui Li Miao DFI
 Director of Finance/CFO 50 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,319,999,206 4,185,873,502 ( 44.91 %) 0 44.91 %

Shareholders

NameEquities%Valuation
Feng Sheng Che
36.31 %
3,388,040,891 36.31 % 234 M $
Wei Cheng Guo
11.92 %
1,112,234,399 11.92 % 77 M $
Xian Hui Meng
4.044 %
377,267,528 4.044 % 26 M $
Jiong Long Zhang
2.739 %
255,582,886 2.739 % 18 M $
GF Fund Management Co., Ltd.
0.6004 %
56,020,000 0.6004 % 4 M $
Bosera Asset Management Co., Ltd.
0.3508 %
32,734,000 0.3508 % 2 M $
China Asset Management Co., Ltd.
0.2044 %
19,070,000 0.2044 % 1 M $
Penghua Fund Management Co., Ltd.
0.1620 %
15,119,000 0.1620 % 1 M $
China Asset Management (Hong Kong) Ltd.
0.0544 %
5,071,294 0.0544 % 350 021 $
Yan Ling Chen
0.0429 %
4,000,000 0.0429 % 276 080 $

Company contact information

Sihuan Pharmaceutical Holdings Group Ltd.

22nd floor, Building 4 Zhubang 2000 Business Centre

100025, Beijing

+852 3628 3911

http://www.sihuanpharm.com
address Sihuan Pharmaceutical Holdings Group Ltd.(460)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. Stock Sihuan Pharmaceutical Holdings Group Ltd.
-20.00% 641M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.95% 819B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.42% 638B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.98% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.08% 329B
ABBVIE INC. Stock AbbVie Inc.
+9.05% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.96% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.86% 225B
NOVARTIS AG Stock Novartis AG
+13.30% 217B
AMGEN INC. Stock Amgen Inc.
+8.91% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 460 Stock
  4. Company Sihuan Pharmaceutical Holdings Group Ltd.